Diabetes affects approximately 6% of the population, with 20% developing foot ulcers. Gout affects about 3% of the population, but <40% receive sufficient urate-lowering therapy to prevent or dissolve urate crystal (tophi) deposition in the feet, which can ulcerate and become infected. Among patients with diabetes, 20% also have gout. This study aimed to assess adherence to recommended gout treatment in patients with diabetes and to compare usual care with initial care provided by a nurse-led gout care program. In patients with diabetes, gout is frequently undertreated, particularly when not initially managed in a nurse-led gout care program.

This article contains supplementary material online at https://doi.org/10.2337/figshare.28020806.

This content is only available via PDF.
© 2024 by the American Diabetes Association
2024
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.